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2 
Abstract 23 
With increasing price volatility and growing awareness of the lack of sustainability of 24 
traditional chemical synthesis, microbial chemical production has been tapped as a 25 
promising renewable alternative for the generation of diverse, stereospecific compounds.  26 
Nonetheless, many attempts to generate them are not yet economically viable.   Due to 27 
the zero sum nature of microbial resources, traditional strategies of pathway optimization 28 
are attaining minimal returns.  This result is in part a consequence of the gross changes in 29 
host physiology resulting from such efforts and underscores the need for more precise 30 
and subtle forms of gene modulation.   In this review, we describe alternative strategies 31 
and emerging paradigms to address this problem and highlight potential solutions from 32 
the emerging field of synthetic biology. 33 
 34 
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3 
Introduction 35 
Microbial production systems display a remarkable flexibility in the diversity and 36 
enantioselectivity of the compounds that they can generate.  These compounds have 37 
historically been natural products such as ethanol, amino acids, acetone and antibiotics.  38 
However, with the introduction of ever more sophisticated tools, a range of natural and 39 
unnatural products have been made in engineered hosts including compounds such as  40 
hydroxyacids[1-3], isoprenoids[4, 5], polyketides[6, 7], and biopolymers[8, 9].  While 41 
several of these processes have been successfully commercialized [10-12], many remain 42 
economically infeasible and are the subject of intense optimization efforts. 43 
In optimizing microbial pathways, the objectives are to maximize product flux, 44 
yield and selectivity.  Traditionally, this problem has been approached by an analysis of 45 
the metabolic pathway that leads to removing branch points that lower product yield and 46 
selectivity (gene inactivation) and increasing the flux of intermediates through the 47 
pathway (gene overexpression).  The power of such methods has improved tremendously 48 
with the advent of computational tools such as Flux Balance Analysis (FBA) [13, 14] and 49 
bilevel optimization [15-17] to identify flux bottlenecks, y t, they are still fundamentally 50 
constrained by the interconnectedness and finite nature of microbial resources (Figure 1).  51 
Gene inactivations may necessitate media supplementation, impair cellular function and 52 
are sometimes infeasible for non-linear production pathways.  Overexpression of 53 
pathway genes, on the other hand,  comes at the expense of endogenous ones due to 54 
consumption of common precursors and titration of cellular machinery such as 55 
polymerases and ribosomes and may lead to growth inhibition, reduced expression and 56 
even cell death [18-20].  In certain hosts the heat shock response is stimulated by protein 57 
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4 
overexpression [21, 22] further limiting the degree of overexpression possible. Moreover, 58 
successfully overexpressing or knocking out genes does not guarantee improved 59 
productivity.  Decoupling the native regulation of flux within the pathway in these ways 60 
may lead to the accumulation of intermediates that can inhibit pathway enzymes [3, 23] 61 
or are bacteriostatic [1, 24, 25].   These challenges are not insurmountable, but they do 62 
underscore the need for more tools in pathway optimization.  This review will highlight 63 
novel approaches to pathway optimization and describe emerging paradigms for flux 64 
manipulation.   65 
 66 
Downregulation of related pathways 67 
Modulation of gene expression, such as downregulation of undesired branch 68 
points, has been identified as a fruitful avenue for increased pathway productivity [16, 69 
17].  In contrast to gene inactivation, downregulation offers the ability to redirect 70 
metabolite flux into production pathways while maintaining sufficient flux for 71 
endogenous processes.  Moreover, in cases of drastic differences in catalytic efficiency of 72 
competing enzymes, it may prove more efficient than over xpression of pathway 73 
enzymes.   Downregulation may be implemented in many different ways.   One 74 
promising method, amenable to implementation in a wide variety of hosts and pathways, 75 
is the use of antisense RNA (asRNA) mediated inhibition of translation [26-30].   76 
One such example of asRNA use in pathway optimization is found in the 77 
engineering of Clostridium acetobutylicum. Predating the rise of petrochemical sources, 78 
C. acetobutylicum was an industrially relevant source of solvents such as acetone and 79 
butantol [33] which it naturally ferments as part of its lifecycle [31, 32].  Recent volatility 80 
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5 
in the price of chemical feedstocks and increasing concern regarding the sustainability of 81 
traditional chemical synthetic routes have led to renewed interest in the species with a 82 
focus on controlling the distribution of products [27, 29, 34, 35].   The Papoutsakis group 83 
used an asRNA approach to downregulate the CoA transferase which catalyzes the 84 
formation of acetone (ctfA1) to shift these strains to a primarily alcohologenic mode of 85 
production (ethanol and butanol), obtaining the highest ethanol titers reported at the time 86 
in C. acetobutylicum [29, 34].   Similar success has been reported for the engineering of 87 
glutamate synthesis fr m Corynebacterium glutamicum.  C. glutamicum is a natural 88 
overproducer of amino acids and an industrial source of several of these including 89 
glutamate [36] which is produced from the transamination of α-ketoglutarate, a citric acid 90 
cycle intermediate.  Utilizing an asRNA approach, Kim and coworkers [28] increased the 91 
cell specific productivity of glutamate by inhibiting activity of 2-oxoglutarate 92 
dehydrogenase thereby allowing sufficient flux of α-ketoglutarate through the citric acid 93 
cycle for energy production while diverting additional precursors to increase glutamate 94 
synthesis.  Finally, asRNA technology has been utilized in the synthesis of cobalamin 95 
(Vitamin B12) in Bacillus megaterium to improve titers and yields by 20% [30]. 96 
 The use of downregulation extends beyond the realm of small molecule synthesis 97 
and has similar applications in  recombinant protein production where acetate has been 98 
established to have an inhibitory effect on specific protein expression and bacterial 99 
growth [37-40].  Controlling acetate production by inactivation of phosphotransacetylase 100 
(pta) or acetate kinase (ackA) genes in E. coli, which shunt excess acetyl-CoA to acetate, 101 
has a deleterious effect on the cellular redox state [40], carbon flux [41], and ultimately 102 
growth [41].  Diverse solutions such as process-based schemes [37] and metabolic 103 
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6 
engineering of the host to shunt the excess acetyl-CoA to acetoin [39] have been 104 
developed to address the issue. Nonetheless, these solutions are not scalable to all 105 
methods of culture and inhibit ATP synthesis by acetate secretion.  Thus, Kim and Cha 106 
[42] chose an antisense based scheme to minimize detrimental physiological effects.  107 
Through minor antisense inhibition of ackA and pta, Kim and Cha were able to reduce 108 
acetate formation by more than 20% while simultaneously observing a 60% improvement 109 
in the production of green fluorescent protein with negligible impact on cellular growth.  110 
These examples of asRNA inhibition are not the only examples of pathway 111 
downregulation.  Alternative strategies such as those utilizing the effect of codon bias on 112 
translational efficiency in C. glutamicum [43, 44], repressible promoters in S. cerevisiae 113 
[45-47] and titrating inducible promoters in E. coli [48] have been used with great 114 
success to increase product yields and/or titers.  Moreover, the last decade has seen 115 
intense efforts to regulate genes at the transcriptional and post translational levels 116 
culminating in several novel methods such as regulated suppression of amber mutations 117 
[49], inducible protein degradation [50], engineered allostery [51] and riboregulators [52, 118 
53].  Despite the fact that many of these emerging technologies have yet to mature and 119 
attain widespread adoption, particularly in an industrial context, the growing interest in 120 
asRNA points to its relative ease of implementation.  While unexplored in these studies, 121 
another advantage of downregulation is the possibility of dynamic control of gene 122 
expression. 123 
 124 
Dynamic Expression Profiles 125 
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7 
 When maximizing product titers and yields for industrial scale fermentation, 126 
carbon flux is shifted from the normal balance of metabolic intermediates and shunted 127 
into the desired product.   This shift is frequently at odds with the goals of the cell, i.e. 128 
maintaining metabolic flux levels and maximizing biomass.   Thus, genetic alterations 129 
that alter metabolic flux will incur a redistribution of metabolites to compensate for the 130 
change with some inhibition of growth.  Gadkar et al. [54] studied this issue in silico as it 131 
applied to glycerol and ethanol production.  In their work, they pursued a bilevel 132 
optimization strategy analogous to that of OptKnock [15] where product titers are  133 
maximized subject to growth maximization and other physical constraints to determine 134 
gene candidates for upregulation or deletion.  However, unlike OptKnock, they also 135 
optimized the timing of these genetic changes.  For glycerol production, simulations of a 136 
biphasic approach to gene expression resulted in a 30% improvement in titers over a 137 
static strategy.  Similarly, ethanol titers were improved by 40% over a static strategy and 138 
90% over wildtype behavior. These cases and more were further studied by Anesiadis 139 
and coworkers [55] with the simulated behavior of genetic elements from synthetic 140 
biology, as opposed to instantaneous switching in expression, and came to a similar 141 
conclusion: dynamic control of gene expression may be implemented to increase pathway 142 
productivity. 143 
 One of the first experimental demonstrations of this paradigm was elegantly 144 
performed in 2000.  In trying to produce lycopene in E. coli, Farmer and Liao [56] sought 145 
to overexpress 2 key rate limiting enzymes: phosphoenolpyruvate synthase (Pps), which 146 
controls the pool of a glycolytic intermediate needed for lycopene biosynthesis, and 147 
isopentenyl diphosphate isomerase (Idi), which pulls glycolytic intermediates into the 148 
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8 
lycopene biosynthetic pathway.  However, overexpressing them statically from a tac 149 
promoter hindered growth, yields and titers.  Thus, they engineered a gene 150 
circuit/metabolite control system in which expression of pps and idi was directly tied to 151 
the availability of acetyl phosphate, a proxy for glycolytic flux and cellular health.    152 
Using this approach, they were able to overexpress these enzymes to higher levels than 153 
that seen using a static approach while maintaining cellular viability and ultimately 154 
improve titers by 50%, productivity three-fold and carbon yields by more than an order of 155 
magnitude.  Similar control systems have also been developed to drive protein expression 156 
through the use of quorum sensing  in E. coli [57, 58].  Such systems allow for 157 
coordinated delayed induction across multiple cellular populations in addition to 158 
transmitting the metabolic load state of the host [59] thereby mitigating potential 159 
challenges associated with protein overexpression. Moreover, they are modular and 160 
readily amenable to integration in complex circuits [57] where Boolean logic and sensor 161 
functions can be implemented for tight pathway regulation in combination with other 162 
strategies for cumulative effects.  A hypothetical example of this is presented in Figure 2 163 
where sensing and logic (AND) operations are used to driv  expression of pathway genes 164 
and product only when high cell densities and carbon flux are achieved. 165 
 166 
Emerging paradigms 167 
With an eye towards the creation of sophisticated gene circuits and networks for 168 
both pathway regulation and biosynthesis, the emerging discipline of synthetic biology 169 
has established a paradigm of developing reusable modules or “parts” and “devices” to 170 
control gene expression [60-62].   Towards this end, libraries of sensors, control 171 
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9 
elements, promoters [63-65], and ribosome binding sites (RBS) [66] among others have 172 
been developed.  Many of these libraries are curated within the Registry of Standard 173 
Biological Parts (http://partsregistry.org) and are freely available to the community. 174 
Through these libraries of parts, network components may be individually selected, tuned 175 
and regulated to achieve the necessary phenotype. 176 
The rise of part libraries has also been accompanied by the development of 177 
computer aided design (BioCAD) tools to facilitate the design of ever more complex 178 
circuits [67-71].  However, they are dependent on the availability of  datasheets [72] or 179 
other experimental characterization to describe them which are typically context 180 
dependent and not readily generalizable to all scenarios.   Moreover, the current lack of 181 
generic insulators for these parts results in feedback from downstream parts, or 182 
retroactivity [73], which can further perturb performance from expectation.  Nonetheless, 183 
there has been some success with the engineering of systems from these libraries using 184 
both theoretical and experimental approaches.  For example, using an equilibrium 185 
statistical thermodynamic model, Salis and coworkers [74] were able evaluate the effects 186 
of the 5’ UTR on translation culminating in the design of novel RBSs able to achieve 187 
expression levels spanning 5 orders of magnitude.  Their software tool, RBSCalculator 188 
(https://salis.psu.edu/software/), also allows for relative expression tuning of a given 189 
sequence.  Empirical and combinatorial approaches to the tuning of gene expression from 190 
library components have also proven successful in optimizing yields of lycopene and 191 
mevalonate production pathways [63, 75].   Finally, a combination of both theoretical and 192 
experimental characterization has been used to design and develop tuned systems with 193 
little post hoc adjustment [76]. 194 
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10 
More recently, new part classes such as engineered enzyme complexes have been 195 
developed.  As discussed previously, manipulating flux gives rise to a myriad of 196 
challenges such as the physiological consequences of flux imbalance and titration of 197 
cellular machinery.  These undesired effects can be attenuated with gene modulation and 198 
gene circuits with some tradeoff in selectivity due to reduced pathway intermediates.   199 
Inspired by natural solutions to minimize this tradeoff [77, 78], Deuber et al. [79] 200 
engineered an enzyme scaffold scheme to recruit multiple pathway enzymes in a single 201 
complex.   By colocalizing enzymes in this way, diffusional limitations are effectively 202 
nullified and toxic metabolites can be maintained at locally high, but globally low, 203 
concentrations to maximize pathway flux with minimal disruption to endogenous 204 
processes.  Furthermore, this scaffolding is scalable and generalizable to many enzymes 205 
and pathways in specified stoichiometries allowing for efficient spatial organization of 206 
pathway genes [79-81].  Using this system, mevalonate titers were improved by 70-fold 207 
when compared to scaffold free control.   Moreover, with rate limiting enzymes being 208 
expressed at nominally low levels, the scaffolded constructs were able to achieve these 209 
yields without the growth inhibition seen in an unscaffolded design [79].  Alternative 210 
strategies such as direct protein fusions have also proved successful in improving 211 
pathway productivity [81]. 212 
 213 
Conclusions and Perspectives 214 
 Microbial production systems have enormous potential to synthesize many 215 
valuable chemical compounds in a sustainable manner.   However, optimizing these 216 
systems for economic feasibility remains a challenge, in part, due to the zero sum nature 217 
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11 
of intracellular metabolites (Figure 1).   Redirecting these metabolites into pathways of 218 
interest necessitates a loss of flux elsewhere and titration of cellular machinery away 219 
from endogenous processes resulting in negative physiological consequences.  These 220 
concerns may be attenuated to some degree by microbial consortia.  Such mixed 221 
populations of cells are able to achieve more complex tasks, are more robust to 222 
environmental changes and are able to be organized by function [82].  More importantly, 223 
this functional specialization allows for the distribution of the metabolic burden across 224 
populations resulting in overall healthier cultures and potentially more efficient 225 
pathways.  This advantage is offset, however, by the recalcitrant nature of genetic 226 
manipulations of all but a few species and the potential for competition between 227 
populations making a single organism, single population solution the most tractable 228 
solution for the immediate future. 229 
 Despite the limitations of finite cellular resources, the use of tools which precisely 230 
modulate expression levels has led to much improvement in pathway function by 231 
mitigating the effects of the pathway on host physiology.  Synthetic biology has further 232 
contributed genetic parts and tools that allow for more precise application of regulation 233 
through mechanisms such as basic computation [66, 83, 84], sensing[56, 85] and timed 234 
expression [57, 58] with demonstrated improvements in productivity.  Moreover, these 235 
modifications may all be combined for cumulative pathway improvement (Figure 2).  236 
With increased understanding of the consequences of metabolic perturbations and 237 
evermore sophisticated regulation of expression, yields of microbial production systems 238 
may soon be economically competitive with traditional synthesis culminating in the 239 
realization of widespread microbial production. 240 
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Figure Captions 
Figure 1 
The zero sum challenges with traditional pathway optimization strategies.  In the original 
pathway (A), only one media supplement (yellow circle) is needed to generate product 
(blue circle) and essential metabolites (aqua circle).   However, gene inactivation (B) 
necessitates additional supplementation to generate the essential metabolite while 
overexpression (C) increases the pool of desired intermediate at the expense of 
expression and flux through the other enzymatic steps potentially limiting growth.  The 
sum of these effects on the host’s health controls the degree of success on overall 
pathway production.  Metabolite flux is proportional to the line thickness while 
metabolite pool size is represented by the circle area.  Dashed lines indicate an absence of 
metabolite flux/pools when compared to wildtype. 
 
Figure 2 
A hypothetical example of a complex regulatory circuit utilizing multiple modules or 
parts.  The LuxR/LuxI quorum sensing system (luxI not shown), mediated by N-acyl 
homoserine lactone (AHL),  is used to drive the expression of glnAp2, an acetyl 
phosphate (ACP) sensor [86].  Sufficient carbon flux through central metabolism will 
lead to accumulation of ACP.  The presence of GlnAp2 and ACP serve as inputs to an 
AND gate (binding of ACP to GlnAp2) whose output is expression of pathway genes 
and, ultimately, synthesis of product (triangles).   Product is only produced when biomass 
and carbon flux is high, i.e. from a healthy culture. 
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Figure 1 
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Figure 2  
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Fig 1 . The zero sum challenges with traditional pathway optimization strategies.  In the original 
pathway (A), only one media supplement (yellow circle) is needed to generate product (blue circle) 
and essential metabolites (aqua circle).   However, gene inactivation (B) necessitates additional 
supplementation to generate the essential metabolite while overexpression (C) increases the pool of 
desired intermediate at the expense of expression and flux through the other enzymatic steps 
potentially limiting growth.  The sum of these effects on the host’s health controls the degree of 
success on overall pathway production.  Metabolite flux is proportional to the line thickness while 
metabolite pool size is represented by the circle area.  Dashed lines indicate an absence of 
metabolite flux/pools when compared to wildtype.  
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Figure 2. A hypothetical example of a complex regulatory circuit utilizing multiple modules or parts. 
 The LuxR/LuxI quorum sensing system (luxI not shown), mediated by N-acyl homoserine lactone 
(AHL),  is used to drive the expression of glnAp2, an acetyl phosphate (ACP) sensor [86].  Sufficient 
carbon flux through central metabolism will lead to accumulation of ACP.  The presence of GlnAp2 
and ACP serve as inputs to an AND gate (binding of ACP to GlnAp2) whose output is expression of 
pathway genes and, ultimately, synthesis of product (triangles).   Product is only produced when 
biomass and carbon flux is high, i.e. from a healthy culture.  
138x73mm (300 x 300 DPI)  
 
 
Page 24 of 24
Wiley-VCH
Biotechnology Journal
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
